FDA Inspection 1231859 — Harrow Eye LLC

Harrow Eye LLC — FEI 3019942827

The FDA completed an inspection of Harrow Eye LLC on Oct 10, 2024 in Nashville, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Oct 10, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Nashville, TN (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.